"NorthShore University HealthSystem (NorthShore) is an integrated healthcare delivery system consistently ranked as a Top 15 Teaching Hospital in the U.S. The NorthShore system, headquartered in Evanston, Ill., includes four hospitals – Evanston, Glenbrook, Highland Park and Skokie. NorthShore also includes a 900 physician multispecialty group practice, NorthShore Medical Group, with 130 locations in the Chicagoland area. NorthShore has annual revenues of $2.1 billion and employs 10,500 people."

During the past decade, NorthShore University HealthSystem-Glenbrook Hospital conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 52 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 41 clinical trials were completed. i.e. 74.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NorthShore University HealthSystem-Glenbrook Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorthShore University HealthSystem-Glenbrook Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "National Eye Institute (NEI)" with 5 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "NorthShore University HealthSystem-Glenbrook Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (5 trials) and "Stage II Breast Cancer" (5 trials). Many other conditions were trialed in "NorthShore University HealthSystem-Glenbrook Hospital" in a lesser frequency.

Most popular intervention types in "NorthShore University HealthSystem-Glenbrook Hospital" are "Drug" (120 trials), "Other" (87 trials), "Biological" (60 trials), "Procedure" (46 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (40 trials), "Laboratory Biomarker Analysis" (35 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.

The vast majority of trials in "NorthShore University HealthSystem-Glenbrook Hospital" are 128 trials for "All" genders, 21 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "NorthShore University HealthSystem-Glenbrook Hospital". undefined are not yet recruiting, 45 are recruiting, 66 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in NorthShore University HealthSystem-Glenbrook Hospital, 3 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in NorthShore University HealthSystem-Glenbrook Hospital, 4 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".